Skip to main content
CDC Website

Search Results

Results 11 - 20 of 18141

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

This notice of funding opportunity (NOFO) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention...

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment...

Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to encourage pilot and/or feasibility research in the following areas: 1) the development and pilot testing of new or adapted interventions to prevent or delay the initiation of substance use and/or the progression from use to misuse or...

Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to provide continuing support for specific pathogen-free (SPF) macaque colonies previously funded under the auspices of PAR-21-089 and PAR-18-669 that support Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS)...

Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

This NOFO invites applications at the intersection of HIV and aging by proposing research that aims to meet the following objectives: 1) Improve the understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) Improve...

Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)

Application Due Date:
Funding Organization:
The US Department of Health and Human Health Resources and Services Administration

This NOFO invites applications at the intersection of HIV and aging by proposing research that aims to meet the following objectives: 1) Improve the understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) Improve...

Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

This initiative will support multilevel and multidisciplinary intervention research to improve quality of life and promote successful aging among people with HIV with HIV associated non-AIDS comorbidities across the life course from racial and ethnic and lower socioeconomic status groups.

Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of a comprehensive and well-defined product development strategy for next-generation treatments for HIV and HIV-associated comorbidities, coinfections and complication and preventive strategies for HIV, as well as...

Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

The Population Assessment of Tobacco and Health (PATH) Study provides the scientific community with biospecimens (urine, plasma, serum, and genomic DNA) and related research data on behaviors, attitudes, biomarkers and health outcomes associated with tobacco use in the U.S. This opportunity allows...

Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed

Application Due Date:
Funding Organization:
The US Department of Health and Human Services National Institutes of Health

The purpose of this Notice of Funding Opportunity (NOFO) is to identify cure strategies suitable for administration at the start of combination antiretroviral therapy (cART) and/or at cART restart after an analytical treatment interruption (ATI), with the ultimate goal of achieving sustained...

Was this page helpful? Give Feedback